Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm Metastasis × tremelimumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Liver Neoplasms 2 Carcinoma, Hepatocellular 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Lung Cancer Metastatic 1 Hydronephrosis 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Adenocarcinoma, Follicular 1

Interventions

Specimen Handling 32 Biopsy 30 Magnetic Resonance Spectroscopy 21 pembrolizumab 18 Nivolumab 12 trastuzumab deruxtecan 9 Paclitaxel 9 Pemetrexed 8 Cisplatin 8 Carboplatin 8 Taxes 7 Leucovorin 6 Irinotecan 6 Ipilimumab 6 Gemcitabine 6 Fulvestrant 6 Fluorouracil 6 Cetuximab 6 Capecitabine 6 130-nm albumin-bound paclitaxel 6 X-Rays 5 Radiosurgery 5 Oxaliplatin 5 Cyclophosphamide 5 abemaciclib 4 Trastuzumab 4 Drug Therapy 4 Doxorubicin 4 tislelizumab 3 talazoparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡